MedPath
Found 2 clinical trials|View Analysis
Sort by:

A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy

Phase 1
Terminated
Conditions
Cardiomyopathy, Hypertrophic Obstructive
Interventions
Drug: CT-G20
Drug: Placebo
First Posted Date
2020-06-05
Last Posted Date
2023-03-02
Lead Sponsor
Celltrion
Target Recruit Count
23
Registration Number
NCT04418297
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

Tufts Medical Center, Boston, Massachusetts, United States

🇵🇱

Institute of Cardiology in Warsaw, Warsaw, Mazowieckie, Poland

and more 8 locations

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: CT-G20 Placebo
Drug: CT-G11 Placebo
Drug: CT-G11
Drug: CT-G20
First Posted Date
2019-04-18
Last Posted Date
2020-06-09
Lead Sponsor
Celltrion
Target Recruit Count
72
Registration Number
NCT03918967
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath